News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
454,020 Results
Type
Article (40939)
Company Profile (120)
Press Release (412961)
Section
Business (121687)
Career Advice (813)
Deals (21593)
Drug Delivery (101)
Drug Development (73236)
Employer Resources (60)
FDA (15181)
Job Trends (9610)
News (237728)
Policy (28754)
Tag
Academia (2083)
Alliances (33007)
Alzheimer's disease (1236)
Antibody-drug conjugate (ADC) (102)
Approvals (15116)
Artificial intelligence (120)
Bankruptcy (210)
Best Places to Work (7490)
Biotechnology (91)
Breast cancer (166)
Cancer (1207)
Cardiovascular disease (108)
Career advice (690)
Cell therapy (213)
Clinical research (58830)
Collaboration (406)
Compensation (158)
COVID-19 (2095)
Data (1235)
Diabetes (184)
Diagnostics (3475)
Drug discovery (89)
Drug pricing (104)
Earnings (46019)
Events (62702)
Executive appointments (298)
FDA (15868)
Funding (322)
Gene therapy (176)
GLP-1 (654)
Government (3938)
Healthcare (12277)
Infectious disease (2173)
Inflammatory bowel disease (97)
Interviews (104)
IPO (10099)
Job creations (2423)
Job search strategy (629)
Layoffs (368)
Legal (5467)
Lung cancer (184)
Lymphoma (95)
Manufacturing (176)
Medical device (7141)
Medtech (7144)
Mergers & acquisitions (11619)
Metabolic disorders (498)
Neuroscience (1551)
NextGen: Class of 2025 (3844)
Non-profit (2671)
Northern California (1330)
Obesity (284)
Opinion (215)
Parkinson's disease (89)
Patents (104)
People (35133)
Phase I (17685)
Phase II (25650)
Phase III (19987)
Pipeline (456)
Policy (87)
Postmarket research (2723)
Preclinical (7527)
Radiopharmaceuticals (197)
Rare diseases (243)
Real estate (3037)
Regulatory (20807)
Research institute (1763)
Resumes & cover letters (119)
Southern California (1149)
Startups (2461)
United States (11061)
Vaccines (447)
Weight loss (225)
Date
Today (183)
Last 7 days (280)
Last 30 days (1452)
Last 365 days (26029)
2025 (280)
2024 (26554)
2023 (29532)
2022 (37865)
2021 (39750)
2020 (37021)
2019 (30306)
2018 (23335)
2017 (23709)
2016 (22043)
2015 (25413)
2014 (19041)
2013 (15589)
2012 (16812)
2011 (17305)
2010 (16224)
Location
Africa (539)
Asia (29321)
Australia (4900)
California (2920)
Canada (1062)
China (292)
Colorado (121)
Connecticut (144)
Europe (63489)
Florida (450)
Illinois (258)
Indiana (168)
Japan (88)
Maryland (504)
Massachusetts (1997)
Minnesota (150)
New Jersey (921)
New York (860)
North Carolina (535)
Northern California (1330)
Ohio (108)
Pennsylvania (611)
South America (656)
Southern California (1149)
Texas (407)
Washington State (320)
454,020 Results for "parenteral drug association".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Lone Star Bio
The Foundation for Angelman Syndrome Therapeutics (FAST) announces the establishment of an associated drug development accelerator
The Foundation for Angelman Syndrome Therapeutics (FAST) announced the establishment of an associated drug development accelerator called AS2Bio Inc.
June 4, 2024
·
3 min read
GLP-1
Lilly’s Zepbound Snags First Ever Sleep Apnea Drug Approval
The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in combination with diet and exercise.
December 23, 2024
·
2 min read
·
Kate Goodwin
News
Protara Therapeutics Granted FDA Fast Track Designation for Intravenous Choline Chloride for Patients Receiving Parenteral Support
October 21, 2024
·
7 min read
Drug pricing
Drug Price Watchdog Calls Out Five Pharmas for Unjustified Price Hikes
The Institute for Clinical and Economic Review flagged five drugs whose prices were raised in 2023 with no evidence to support it. Meanwhile, the makers of these drugs have been reporting double-digit sales growth for many of these products.
December 13, 2024
·
3 min read
·
Annalee Armstrong
Policy
Association for Diagnostics & Laboratory Medicine (formerly AACC) survey finds that FDA’s final laboratory developed tests rule will impede the fight against the U.S.'s drug epidemic
The Association for Diagnostics & Laboratory Medicine released the results of a survey that ADLM conducted to determine how the Food and Drug Administration’s final laboratory developed tests rule will impact patient access to essential tests.
June 25, 2024
·
4 min read
Press Releases
U.S. Food and Drug Administration issues Complete Response Letter for the glepaglutide New Drug Application for the treatment of short bowel syndrome
December 20, 2024
·
8 min read
Parkinson’s disease
Roche’s Prothena-Partnered Parkinson’s Drug Fails Mid-Stage Trial
The report comes just two days after Novartis announced its own Parkinson’s drug failure.
December 19, 2024
·
1 min read
·
Annalee Armstrong
BioMidwest
NeuroTherapia Receives Grant from Alzheimer’s Association for Development of First-in-Class Drug for Alzheimer’s Disease
NeuroTherapia, an early-stage clinical pharmaceutical company, announced that it has received a grant from the Alzheimer’s Association Part the Cloud program for the development of its first-in-class drug, NTRX-07, for the treatment of Alzheimer’s disease.
May 8, 2024
·
2 min read
BioMidwest
The American Diabetes Association Highlights Innovations in New Drug Therapies for Patients with Obesity
Findings from three studies showcase new data on the latest developments in drug therapy innovations to treat obesity including new insights on GLP-1 receptor agonists.
June 23, 2024
·
9 min read
Deals
Sarepta Aims Up to $10B at Arrowhead to Diversify Pipeline With RNA Drugs
With Elevidys expansion in hand, Sarepta commits up to $10 billion to develop short interfering RNA–based drugs to build out its pipeline.
November 26, 2024
·
2 min read
·
Kate Goodwin
1 of 45,402
Next